Summary
Miromatrix Medical Inc (Miromatrix Medical), a subsidiary of United Therapeutics Corp is a biotechnology company that focuses on the development of transplantable human organs. The company's products include mirokidney is for the treatment of end-stage liver disease; mirokidney targets end-stage renal disease; miroliverelap for acute liver failure. The company utilizes perfusion decellularization and perfusion recellularization technologies to develop its organs. It collaborates with several institutions including Baxter, CareDx, the Mayo Clinic, Mount Sinai, and the Texas Heart Institute. Miromatrix Medical is headquartered in Eden Prairie, Minnesota, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Miromatrix Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Miromatrix Medical Inc Company Overview
- Miromatrix Medical Inc Company Snapshot
- Miromatrix Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Miromatrix Medical Inc - Pipeline Analysis Overview
- Miromatrix Medical Inc - Key Facts
- Miromatrix Medical Inc - Major Products and Services
- Miromatrix Medical Inc Pipeline Products by Development Stage
- Miromatrix Medical Inc Ongoing Clinical Trials by Trial Status
- Miromatrix Medical Inc Pipeline Products Overview
- Cortical Strut
- Cortical Strut Product Overview
- Extracorporeal Liver Graft
- Extracorporeal Liver Graft Product Overview
- Liver Construct
- Liver Construct Product Overview
- Miro Liver
- Miro Liver Product Overview
- Miro Pancreas
- Miro Pancreas Product Overview
- Miroheart
- Miroheart Product Overview
- Mirokidney
- Mirokidney Product Overview
- MiroliverELAP
- MiroliverELAP Product Overview
- MiroliverELAP Clinical Trial
- Mirolung
- Mirolung Product Overview
- Recellularized Implantable Total Liver
- Recellularized Implantable Total Liver Product Overview
- Transplantable Liver
- Transplantable Liver Product Overview
- Miromatrix Medical Inc - Key Competitors
- Miromatrix Medical Inc - Key Employees
- Miromatrix Medical Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Miromatrix Medical Inc, Recent Developments
- May 30, 2023: Miromatrix presenting at the 2023 American Transplant Congress
- Apr 05, 2023: CareDx and Miromatrix announce exclusive partnership to advance research using bioengineered organs for human transplantation
- Feb 01, 2023: Miromatrix provides update on miroliverELAP
- Feb 01, 2023: Miromatrix and Baxter announce collaborative research agreement aiming to advance care for patients with acute liver failure
- Dec 14, 2022: Miromatrix announces FDA clinical hold on IND application for miroliverELAP
- Sep 26, 2022: Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
- Sep 20, 2022: Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
- Aug 01, 2022: Miromatrix to Report Second Quarter 2022 Financial Results
- May 25, 2022: Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference
- Apr 19, 2022: Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Med
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Miromatrix Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Miromatrix Medical Inc Pipeline Products by Equipment Type
- Miromatrix Medical Inc Pipeline Products by Indication
- Miromatrix Medical Inc Ongoing Clinical Trials by Trial Status
- Miromatrix Medical Inc, Key Facts
- Miromatrix Medical Inc, Major Products and Services
- Miromatrix Medical Inc Number of Pipeline Products by Development Stage
- Miromatrix Medical Inc Pipeline Products Summary by Development Stage
- Miromatrix Medical Inc Ongoing Clinical Trials by Trial Status
- Miromatrix Medical Inc Ongoing Clinical Trials Summary
- Cortical Strut - Product Status
- Cortical Strut - Product Description
- Extracorporeal Liver Graft - Product Status
- Extracorporeal Liver Graft - Product Description
- Liver Construct - Product Status
- Liver Construct - Product Description
- Miro Liver - Product Status
- Miro Liver - Product Description
- Miro Pancreas - Product Status
- Miro Pancreas - Product Description
- Miroheart - Product Status
- Miroheart - Product Description
- Mirokidney - Product Status
- Mirokidney - Product Description
- MiroliverELAP - Product Status
- MiroliverELAP - Product Description
- MiroliverELAP - A Phase 1 Prospective Study of the Miromatrix External Liver Assist Product (miroliverELAP) for Liver Support in Adults with Acute Liver Failure
- Mirolung - Product Status
- Mirolung - Product Description
- Recellularized Implantable Total Liver - Product Status
- Recellularized Implantable Total Liver - Product Description
- Transplantable Liver - Product Status
- Transplantable Liver - Product Description
- Miromatrix Medical Inc, Key Employees
- Glossary
- Miromatrix Medical Inc Pipeline Products by Equipment Type
- Miromatrix Medical Inc Pipeline Products by Development Stage
- Miromatrix Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- eGenesis Inc
- Ossium Health Inc
- Organovo Holdings Inc
- Prellis Biologics Inc
- Syncardia Systems LLC
